International
“Human error”: Curaleaf switches CBD for THC and faces seven lawsuits in US courts
A Curaleaf Holdings Inc., a Massachusetts-based multinational cannabis company, is facing seven federal lawsuits over Select-branded products because buyers ingested THC from CBD-labeled bottles. Curaleaf has already admitted that there was “unintentional human error” that led to the production of a batch of CBD drops that were actually THC drops, and vice versa.
About 500 bottles were wrongly labeled as CBD drops, containing high levels of THC were sold before the withdrawal from shelves, which could raise the number of charges against the multinational giant. On the other hand, 630 products labeled as THC drops, which contained only CBD, were also sold. Patients who purchased bottles of CBD with incorrect labels may have mistakenly received more than 30 milligrams of THC.
The buyers who filed the seven cases, all brought by the same attorney in US District Court in the State of Oregon, said they suffered a number of adverse effects and undesirable symptoms after taking the oils. Each is seeking compensation of up to 1% of Curaleaf's net worth - around $100 million, based on a report earlier this year in which the company estimated its market capitalization at more than $10 billion. of dollars.
The company said it cooperated with Oregon regulators in pulling out the swapped batches and is reviewing its production processes to avoid similar issues in the future.
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
Dr. Green Digital Key: The Allegations, the Concerns and Why We're Investigating
Over the past eight months, Business of Cannabis, Cannabis Health, Leafie and CannaReporter® have conducted a...
North Macedonia: Government to review company licenses after seizing cannabis destined for the illicit market
“All licenses granted to companies processing cannabis for medicinal purposes will be reviewed.” The government of North Macedonia...
Portugal: New Operation “Ortiga” seizes 2 tons of cannabis and arrests two foreign citizens
The investigation that the Judiciary Police began in May and which targets medicinal cannabis companies in Portugal had today...
Thailand: New cannabis regulations aren't as bad as they seem. Here's what's really at stake in the country
The Thai government recently announced its intention to review its cannabis legislation, with the aim of limiting...
Lorraine Nolan chosen to head European Drugs Agency (EUDA)
The Executive Assembly of the European Drugs Agency (EUDA) has appointed Irishwoman Lorraine Nolan to take up the position of Director...
Cannabis Europa: “Doctors continue to leave medical school without having learned about the endocannabinoid system”
The phrase is from Niall Ivers, co-founder of Cantourage, and reveals a systemic problem in the medicinal cannabis sector in...
Hungary: New drug policy includes zero tolerance and hate campaigns
The Hungarian government, in power for 15 years, has consistently used marginalized groups as scapegoats for its problems,...
SOMAÍ and Universidade Lusófona publish peer-reviewed study to improve practices in the production of full-spectrum cannabis oils
SOMAÍ Pharmaceuticals, a multinational operator with EU-GMP certification, through a partnership with Universidade Lusófona, has published a study...
Poland’s telemedicine setback: A wake-up call for Europe’s cannabis sector
Poland's medical cannabis sector has seen one of the most impressive growth trajectories in Europe — but it's also...
From Renaissance to Revolution: You Can't Spell Mental Health in the 21st Century Without Psychedelics
Psychedelic Science 2025, held in Denver, Colorado, June 16-20, was a fusion of science,...
